As World AMR Awareness Week (WAAW) continues, an ICARS-supported project in the Philippines has completed its work linking vaccination and antimicrobial resistance. A review of 94 studies and a newly launched national network point to vaccines as a practical way to protect antibiotics.
In the Philippines, antimicrobial resistance (AMR) is linked to a high number of deaths each year, and gaps in immunisation coverage, particularly in underserved areas, leave many people exposed to infections that could be prevented. Vaccination offers a practical response. By stopping infections before they start, vaccines can reduce the need for antibiotics and slow the spread of resistant bacteria.
An ICARS-supported project working to strengthen the link between vaccination and AMR in the Philippines is currently underway. Led by the Ateneo School of Medicine and Public Health Center for Research and Innovation (ACRI) in partnership with IQVIA, and co-funded by ICARS and the International Vaccine Institute (IVI), the 20-month project will conclude in November 2026. Its findings are being shared during WAAW, which runs from 18-24 November, following the launch of a national AMR and vaccines network in Quezon City on 19 November.
Bringing immunisation and AMR strategies together
Vaccination programmes and AMR strategies in the Philippines have largely been planned and funded separately. The project set out to connect them, focusing on key pathogen and vaccine pairs including Streptococcus pneumoniae and Haemophilus influenzae, and drawing on data from national immunisation and AMR surveillance programmes.
Over the course of the project, the team carried out a scoping review of published evidence, mapped where real-world data on vaccines and AMR is missing, and developed an action plan for integrating vaccines into national and sub-national AMR strategies. In November 2025, ACRI also convened a roundtable with physician societies and city health officers from across Metro Manila, followed by a community immunisation drive for senior citizens in Valenzuela City.
What the evidence shows
The scoping review covered 94 studies from 15 countries, published between 2015 and 2025. Preliminary findings show that around 30 studies reported fewer infections following vaccination, while around 8 also measured a reduction in antibiotic use. The smaller number reflects how rarely antibiotic use has been tracked directly in vaccine studies and highlights a clear priority for future research.
In Cambodia, Bangladesh and Nepal, resistant bacteria became less common following the introduction of pneumococcal vaccines, which protect against pneumonia and other serious infections. In Cambodia, the number of young children carrying multidrug-resistant pneumococcus in their nose and throat fell by 26% in the first several years after the vaccine was introduced. In Bangladesh, strains covered by the vaccine fell from around 80% to 47% of bacteria found in serious infections, and in Nepal from around 75% to 64%. Many of these strains were among the most resistant to antibiotics.
Only around 7 of the studies reviewed came from the Philippines, and these pointed to gaps in national monitoring. Building stronger local data will allow the country to measure the impact of its own immunisation programmes on resistance and use that evidence to inform policy.
A national network to carry the work forward
Launched on 19 November, the AMR and vaccines network brings together more than 80 participants from over 35 organizations, spanning national government agencies, local government, academic and research institutions, medical and professional societies, hospitals, civil society, industry, student organizations and international partners to take forward the project’s action plan. Its priorities include linking immunisation and AMR surveillance data, building local research capacity, and raising awareness among health workers and the public of the role vaccines play in AMR prevention.
“Vaccines are rarely part of AMR-mitigation planning, even though preventing infections is one of the most direct ways to reduce antibiotic use. This project has brought together the evidence and partnerships needed to change that in the Philippines, and offers an approach other countries in the region can learn from” said Dr Nandini Sreenivasan, Senior Science Advisor at ICARS.
For families, staying up to date on vaccines can mean fewer infections and fewer courses of antibiotics, protecting both their own health and the effectiveness of antibiotics for the wider community.
Read more about the project and follow the team’s WAAW campaign.